Tianjin Lisheng Pharmaceutical Co Ltd SZSE:002393:
SEES FY NET PROFIT ATTRIBUTABLE FOR TIANJIN LISHENG PHARMACEUTICAL RMB400 MILLION TO RMB440 MILLION
Tianjin Development Posts FY Net Profit Attributable Guidance For Tianjin Lisheng Pharmaceutical
Tianjin Lisheng Pharmaceutical Co., Ltd. on 6ix
Earlier from Tianjin Lisheng Pharmaceutical
Later from Tianjin Lisheng Pharmaceutical
- Tianjin Development Posts FY Total Revenue From Ops For Tianjin Lisheng Pharmaceutical RMB1.39 Bln
- Tianjin Development Posts FY Results For Tianjin Lisheng Pharmaceutical
- Tianjin Development Says Tianjin Lisheng Pharmaceutical QTRLY Operating Income RMB 332.28 Mln
Follow Tianjin Lisheng Pharmaceutical into a list and get an email when it puts out news.
Follow Tianjin Lisheng Pharmaceutical